In about two minutes, monitor Platelet Count and real Platelet Aggregation or Inhibition at the point of care using traditional ADP, collagen or the new Arachidonic acid agonists. All that's needed is an impedance cellcounter and Plateletworks.

• Platelet Aggregation
• Platelet Inhibition
• Platelet Count
• CBC

By directly monitoring the platelet's ability to form an aggregate, it's a direct measurement of the platelet's ability to contribute to a thrombus. Plateletworks can be used to monitor all mechanisms which effect platelet aggregation:

• Physiological conditions such as fibrinolytic damage to glycoprotein la

• Aspirin and ADP inhibitors (clopidogrel, ticlopene)

• Antifibrinolytics (aprotinin, EACA)

• Glycoprotein IIb/IIIa inhibitors (abciximab, eptifibatide, tirofiban)

• New Arachadonic Acid agonist is the only screening assay suitable for patients on both clopidogrel and aspirin